Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Purdue Pharma, the maker of the opioid painkiller OxyContin, is reportedly considering filing for bankruptcy as thousands sue the company over its contribution to causing the opioid abuse crisis. (Photo: VCU CNS/Flickr/cc)

"When We Say 'Pharma Greed Kills,' This Is What We Mean": Critics Respond to Possible Purdue Bankruptcy

"Well, this is certainly the Trumpian way out."

Julia Conley

After spending hundreds of millions of dollars convincing the American public that opioid painkillers are safe to use for chronic pain—and fueling a deadly, decades-long addiction epidemic as a result—the drug maker Purdue Pharma could file for bankruptcy to avoid being held accountable for its actions.

According to Reuters, Purdue is considering bankruptcy to halt thousands of lawsuits and allow the company to settle with the plaintiffs out of court.

Critics on social media slammed the manufacturer for apparently seeking a way out of its legal troubles without allowing its accusers to bring their cases to trial.

The lawsuits have been filed in dozens of states—of about 2,000, 1,600 are in a federal court in Ohio, with the remaining litigation spread across the country. A number of state attorneys general, including Maura Healy of Massachusetts and Mike Hunter of Oklahoma, are also suing the company.

Litigants say the company misled the public and the medical community about the safety of OxyContin, the opioid painkiller it released in 1996, and other opioids, which are chemically similar to heroin and are commonly prescribed in pill form for pain management. Purdue and other drug companies spent years assuring Americans that drugs like OxyContin, Vicodin, and Percocet were suitable for long-term use.

"Purdue Pharma and its executives built a multi-billion-dollar business based on deception and addiction," said Healy last year as she announced her state's suit. "The more drugs they sold, the more money they made, and the more people in Massachusetts suffered and died. These defendants must be held accountable for their role in the opioid epidemic that has ravaged our state and claimed so many lives."

Addiction experts say the drugs should only be prescribed for acute pain, such as after surgery or during end-of-life care, due to their highly addictive quality.

A Justice Department report revealed last year that Purdue began receiving reports that some patients were becoming addicted to OxyContin almost immediately after they began selling it.

Opioids were involved in more than 47,000 overdose deaths in 2017. Between 2000 and 2014, overdose deaths from opioids increased by about 200 percent as Purdue Pharma reported rising profits. The company made $45 million in sales of OxyContin the first year it was on the market and reported a 2,000 percent increase by 2000. By 2010, OxyContoin was bringing in $3.1 billion. 

In 2007, the company and three of its top executives pleaded guilty to using deceptive practices to market OxyContin, paying $634.5 million in fines.

But critics have raised concerns that a bankruptcy filing by Purdue could keep victims of the epidemic the company helped fuel from being heard.


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

... We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Critics Warn Biden 'Summit for Democracy' Will Highlight Democrats' Failures at Home

"President Biden can't champion democracy across the globe without fulfilling his promise to protect our voting rights at home."

Jessica Corbett ·


'Like a Teenager Promising to Clean Their Room in 30 Years': Biden Net-Zero Climate Goal for 2050 Ridiculed

"2050 is an extremely weak goal for the federal government to free itself from climate-heating pollution. It ignores existing technology and adds decades to GSA's own commitment to 100% renewable energy by 2025."

Brett Wilkins ·


Biden Should Cancel Student Debt or Watch $85 Billion Evaporate From US Economy: Analysis

Far-reaching cancellation enacted by Biden could add more than $173 billion to the nation's GDP in 2022 alone.

Kenny Stancil ·


Given Cover by Red-Baiting GOP, Corporate Dems Rebuked for Tanking Biden Nominee for Top Bank Regulator

"If you think that Senate Democrats rose up to [Republicans'] shameful display of modern McCarthyism by rallying around President Biden's nominee or her ideas that banking should work for the middle class, then you don't know the soul of today's Democratic Party," wrote one columnist.

Julia Conley ·


'S.O.S.!': Groups in Red States Nationwide Plead With Democrats to Pass Voting Rights Bill

"We can tell you firsthand that our Republican senators have no interest in joining this effort."

Jake Johnson ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo